XP19986 CR
XP-B-049
Phase 2 small_molecule completed
Quick answer
XP19986 CR for GERD is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- GERD
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed